Parkinson Clinical Trials in Dallas, Texas
9 recruitingDallas, Texas
Showing 1–9 of 9 trials
Recruiting
Phase 2
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Parkinson DiseaseParkinsonParkinson Disease, Idiopathic+2 more
Neuron23 Inc.150 enrolled70 locationsNCT06680830
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Parkinson's Disease
Hoffmann-La Roche900 enrolled101 locationsNCT07174310
Recruiting
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Movement DisordersParkinsons DiseaseNeurology
InSightec60 enrolled5 locationsNCT05539196
Recruiting
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
Multiple System AtrophyParkinson DiseaseProgressive Supranuclear Palsy
University of Texas Southwestern Medical Center90 enrolled1 locationNCT03872102
Recruiting
Not Applicable
Action Regulation Behavioral
Parkinson Disease
University of Texas Southwestern Medical Center50 enrolled1 locationNCT06489483
Recruiting
Phase 4
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Parkinson Disease
Impax Laboratories, LLC220 enrolled27 locationsNCT06765668
Recruiting
Not Applicable
SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease
Parkinson Disease
University of Texas Southwestern Medical Center15 enrolled1 locationNCT05982730
Recruiting
Not Applicable
Motor Network Physiology
Parkinson DiseaseEssential Tremor
University of Texas Southwestern Medical Center120 enrolled1 locationNCT04957095
Recruiting
Phase 2
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
Parkinson Disease
Intra-Cellular Therapies, Inc.132 enrolled31 locationsNCT05766813